nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Dezocine—Estrone—prostate cancer	0.255	0.32	CrCrCtD
Pentazocine—Levorphanol—Estrone—prostate cancer	0.198	0.248	CrCrCtD
Pentazocine—Dezocine—Estradiol—prostate cancer	0.193	0.243	CrCrCtD
Pentazocine—Levorphanol—Estradiol—prostate cancer	0.15	0.188	CrCrCtD
Pentazocine—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.00193	1	CbGdCrCtD
Pentazocine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.00017	0.00111	CcSEcCtD
Pentazocine—Paraesthesia—Estradiol—prostate cancer	0.00017	0.00111	CcSEcCtD
Pentazocine—Asthenia—Conjugated Estrogens—prostate cancer	0.00017	0.00111	CcSEcCtD
Pentazocine—Pruritus—Goserelin—prostate cancer	0.000169	0.0011	CcSEcCtD
Pentazocine—Dyspnoea—Estradiol—prostate cancer	0.000169	0.0011	CcSEcCtD
Pentazocine—Somnolence—Estradiol—prostate cancer	0.000168	0.0011	CcSEcCtD
Pentazocine—Anorexia—Mitoxantrone—prostate cancer	0.000168	0.0011	CcSEcCtD
Pentazocine—Pruritus—Conjugated Estrogens—prostate cancer	0.000167	0.00109	CcSEcCtD
Pentazocine—Diplopia—Epirubicin—prostate cancer	0.000167	0.00109	CcSEcCtD
Pentazocine—Visual impairment—Docetaxel—prostate cancer	0.000165	0.00108	CcSEcCtD
Pentazocine—Hypotension—Mitoxantrone—prostate cancer	0.000165	0.00107	CcSEcCtD
Pentazocine—Decreased appetite—Estradiol—prostate cancer	0.000165	0.00107	CcSEcCtD
Pentazocine—Diarrhoea—Goserelin—prostate cancer	0.000163	0.00107	CcSEcCtD
Pentazocine—Erythema multiforme—Docetaxel—prostate cancer	0.000162	0.00106	CcSEcCtD
Pentazocine—Constipation—Estradiol—prostate cancer	0.000162	0.00106	CcSEcCtD
Pentazocine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000162	0.00106	CcSEcCtD
Pentazocine—Face oedema—Epirubicin—prostate cancer	0.000162	0.00105	CcSEcCtD
Pentazocine—Vertigo—Etoposide—prostate cancer	0.000161	0.00105	CcSEcCtD
Pentazocine—Visual impairment—Capecitabine—prostate cancer	0.00016	0.00104	CcSEcCtD
Pentazocine—Flushing—Docetaxel—prostate cancer	0.000159	0.00104	CcSEcCtD
Pentazocine—Paraesthesia—Mitoxantrone—prostate cancer	0.000158	0.00103	CcSEcCtD
Pentazocine—Loss of consciousness—Etoposide—prostate cancer	0.000158	0.00103	CcSEcCtD
Pentazocine—Dizziness—Goserelin—prostate cancer	0.000158	0.00103	CcSEcCtD
Pentazocine—Dyspnoea—Mitoxantrone—prostate cancer	0.000157	0.00103	CcSEcCtD
Pentazocine—Erythema multiforme—Capecitabine—prostate cancer	0.000157	0.00102	CcSEcCtD
Pentazocine—Somnolence—Mitoxantrone—prostate cancer	0.000157	0.00102	CcSEcCtD
Pentazocine—Dizziness—Conjugated Estrogens—prostate cancer	0.000156	0.00102	CcSEcCtD
Pentazocine—Feeling abnormal—Estradiol—prostate cancer	0.000156	0.00102	CcSEcCtD
Pentazocine—Hypertension—Etoposide—prostate cancer	0.000155	0.00101	CcSEcCtD
Pentazocine—Tinnitus—Capecitabine—prostate cancer	0.000155	0.00101	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—prostate cancer	0.000155	0.00101	CcSEcCtD
Pentazocine—Flushing—Capecitabine—prostate cancer	0.000154	0.00101	CcSEcCtD
Pentazocine—Chills—Docetaxel—prostate cancer	0.000154	0.001	CcSEcCtD
Pentazocine—Decreased appetite—Mitoxantrone—prostate cancer	0.000153	0.001	CcSEcCtD
Pentazocine—Vomiting—Goserelin—prostate cancer	0.000152	0.00099	CcSEcCtD
Pentazocine—Constipation—Mitoxantrone—prostate cancer	0.000151	0.000983	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000151	0.000982	CcSEcCtD
Pentazocine—Dermatitis—Goserelin—prostate cancer	0.00015	0.000981	CcSEcCtD
Pentazocine—Vomiting—Conjugated Estrogens—prostate cancer	0.00015	0.000981	CcSEcCtD
Pentazocine—Headache—Goserelin—prostate cancer	0.00015	0.000975	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—prostate cancer	0.000149	0.000975	CcSEcCtD
Pentazocine—Chills—Capecitabine—prostate cancer	0.000149	0.000972	CcSEcCtD
Pentazocine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000149	0.000971	CcSEcCtD
Pentazocine—Headache—Conjugated Estrogens—prostate cancer	0.000148	0.000966	CcSEcCtD
Pentazocine—Confusional state—Etoposide—prostate cancer	0.000148	0.000965	CcSEcCtD
Pentazocine—Hallucination—Prednisone—prostate cancer	0.000147	0.00096	CcSEcCtD
Pentazocine—Anaphylactic shock—Etoposide—prostate cancer	0.000147	0.000957	CcSEcCtD
Pentazocine—Dysgeusia—Docetaxel—prostate cancer	0.000146	0.000954	CcSEcCtD
Pentazocine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000145	0.000948	CcSEcCtD
Pentazocine—Muscle spasms—Docetaxel—prostate cancer	0.000144	0.000937	CcSEcCtD
Pentazocine—Tachycardia—Etoposide—prostate cancer	0.000143	0.000934	CcSEcCtD
Pentazocine—Eosinophilia—Epirubicin—prostate cancer	0.000143	0.000934	CcSEcCtD
Pentazocine—Nausea—Goserelin—prostate cancer	0.000142	0.000925	CcSEcCtD
Pentazocine—Hyperhidrosis—Etoposide—prostate cancer	0.000142	0.000925	CcSEcCtD
Pentazocine—Dysgeusia—Capecitabine—prostate cancer	0.000142	0.000924	CcSEcCtD
Pentazocine—Nausea—Conjugated Estrogens—prostate cancer	0.00014	0.000916	CcSEcCtD
Pentazocine—Anorexia—Etoposide—prostate cancer	0.00014	0.000912	CcSEcCtD
Pentazocine—Hypersensitivity—Estradiol—prostate cancer	0.000139	0.000909	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000139	0.000909	CcSEcCtD
Pentazocine—Muscle spasms—Capecitabine—prostate cancer	0.000139	0.000907	CcSEcCtD
Pentazocine—Flushing—Prednisone—prostate cancer	0.000137	0.000896	CcSEcCtD
Pentazocine—Hypotension—Etoposide—prostate cancer	0.000137	0.000894	CcSEcCtD
Pentazocine—Vision blurred—Capecitabine—prostate cancer	0.000136	0.000889	CcSEcCtD
Pentazocine—Asthenia—Estradiol—prostate cancer	0.000136	0.000886	CcSEcCtD
Pentazocine—Tremor—Capecitabine—prostate cancer	0.000135	0.000884	CcSEcCtD
Pentazocine—Syncope—Docetaxel—prostate cancer	0.000134	0.000874	CcSEcCtD
Pentazocine—Pruritus—Estradiol—prostate cancer	0.000134	0.000873	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—prostate cancer	0.000132	0.000864	CcSEcCtD
Pentazocine—Paraesthesia—Etoposide—prostate cancer	0.000132	0.000859	CcSEcCtD
Pentazocine—Loss of consciousness—Docetaxel—prostate cancer	0.000131	0.000856	CcSEcCtD
Pentazocine—Dyspnoea—Etoposide—prostate cancer	0.000131	0.000853	CcSEcCtD
Pentazocine—Somnolence—Etoposide—prostate cancer	0.00013	0.00085	CcSEcCtD
Pentazocine—Vertigo—Capecitabine—prostate cancer	0.00013	0.000847	CcSEcCtD
Pentazocine—Hypersensitivity—Mitoxantrone—prostate cancer	0.00013	0.000847	CcSEcCtD
Pentazocine—Syncope—Capecitabine—prostate cancer	0.00013	0.000846	CcSEcCtD
Pentazocine—Diarrhoea—Estradiol—prostate cancer	0.00013	0.000844	CcSEcCtD
Pentazocine—Hypertension—Docetaxel—prostate cancer	0.000129	0.000841	CcSEcCtD
Pentazocine—Decreased appetite—Etoposide—prostate cancer	0.000128	0.000832	CcSEcCtD
Pentazocine—Loss of consciousness—Capecitabine—prostate cancer	0.000127	0.000829	CcSEcCtD
Pentazocine—Asthenia—Mitoxantrone—prostate cancer	0.000127	0.000825	CcSEcCtD
Pentazocine—Constipation—Etoposide—prostate cancer	0.000125	0.000818	CcSEcCtD
Pentazocine—Dizziness—Estradiol—prostate cancer	0.000125	0.000816	CcSEcCtD
Pentazocine—Hypertension—Capecitabine—prostate cancer	0.000125	0.000814	CcSEcCtD
Pentazocine—Dry mouth—Docetaxel—prostate cancer	0.000124	0.000811	CcSEcCtD
Pentazocine—Sweating—Epirubicin—prostate cancer	0.000124	0.000806	CcSEcCtD
Pentazocine—Confusional state—Docetaxel—prostate cancer	0.000123	0.000802	CcSEcCtD
Pentazocine—Anaphylactic shock—Docetaxel—prostate cancer	0.000122	0.000795	CcSEcCtD
Pentazocine—Vision blurred—Prednisone—prostate cancer	0.000121	0.000792	CcSEcCtD
Pentazocine—Feeling abnormal—Etoposide—prostate cancer	0.000121	0.000788	CcSEcCtD
Pentazocine—Diarrhoea—Mitoxantrone—prostate cancer	0.000121	0.000787	CcSEcCtD
Pentazocine—Dry mouth—Capecitabine—prostate cancer	0.00012	0.000785	CcSEcCtD
Pentazocine—Vomiting—Estradiol—prostate cancer	0.00012	0.000785	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—prostate cancer	0.00012	0.000785	CcSEcCtD
Pentazocine—Shock—Docetaxel—prostate cancer	0.00012	0.000782	CcSEcCtD
Pentazocine—Dermatitis—Estradiol—prostate cancer	0.000119	0.000777	CcSEcCtD
Pentazocine—Confusional state—Capecitabine—prostate cancer	0.000119	0.000776	CcSEcCtD
Pentazocine—Tachycardia—Docetaxel—prostate cancer	0.000119	0.000776	CcSEcCtD
Pentazocine—Headache—Estradiol—prostate cancer	0.000119	0.000773	CcSEcCtD
Pentazocine—Agitation—Prednisone—prostate cancer	0.000118	0.000772	CcSEcCtD
Pentazocine—Anorexia—Docetaxel—prostate cancer	0.000116	0.000758	CcSEcCtD
Pentazocine—Shock—Capecitabine—prostate cancer	0.000116	0.000757	CcSEcCtD
Pentazocine—Vertigo—Prednisone—prostate cancer	0.000116	0.000755	CcSEcCtD
Pentazocine—Syncope—Prednisone—prostate cancer	0.000116	0.000753	CcSEcCtD
Pentazocine—Tachycardia—Capecitabine—prostate cancer	0.000115	0.000751	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—prostate cancer	0.000114	0.000746	CcSEcCtD
Pentazocine—Hyperhidrosis—Capecitabine—prostate cancer	0.000114	0.000744	CcSEcCtD
Pentazocine—Hypotension—Docetaxel—prostate cancer	0.000114	0.000743	CcSEcCtD
Pentazocine—Loss of consciousness—Prednisone—prostate cancer	0.000113	0.000738	CcSEcCtD
Pentazocine—Anorexia—Capecitabine—prostate cancer	0.000113	0.000734	CcSEcCtD
Pentazocine—Nausea—Estradiol—prostate cancer	0.000112	0.000733	CcSEcCtD
Pentazocine—Vomiting—Mitoxantrone—prostate cancer	0.000112	0.000731	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—prostate cancer	0.000112	0.000727	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—prostate cancer	0.000111	0.000726	CcSEcCtD
Pentazocine—Hypertension—Prednisone—prostate cancer	0.000111	0.000725	CcSEcCtD
Pentazocine—Dermatitis—Mitoxantrone—prostate cancer	0.000111	0.000724	CcSEcCtD
Pentazocine—Headache—Mitoxantrone—prostate cancer	0.00011	0.00072	CcSEcCtD
Pentazocine—Hypotension—Capecitabine—prostate cancer	0.00011	0.000719	CcSEcCtD
Pentazocine—Insomnia—Docetaxel—prostate cancer	0.00011	0.000719	CcSEcCtD
Pentazocine—Paraesthesia—Docetaxel—prostate cancer	0.000109	0.000714	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—prostate cancer	0.000109	0.000714	CcSEcCtD
Pentazocine—Dyspnoea—Docetaxel—prostate cancer	0.000109	0.000709	CcSEcCtD
Pentazocine—Somnolence—Docetaxel—prostate cancer	0.000108	0.000707	CcSEcCtD
Pentazocine—Hypersensitivity—Etoposide—prostate cancer	0.000108	0.000705	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—prostate cancer	0.000108	0.000704	CcSEcCtD
Pentazocine—Flushing—Epirubicin—prostate cancer	0.000107	0.0007	CcSEcCtD
Pentazocine—Insomnia—Capecitabine—prostate cancer	0.000107	0.000696	CcSEcCtD
Pentazocine—Paraesthesia—Capecitabine—prostate cancer	0.000106	0.000691	CcSEcCtD
Pentazocine—Decreased appetite—Docetaxel—prostate cancer	0.000106	0.000691	CcSEcCtD
Pentazocine—Asthenia—Etoposide—prostate cancer	0.000105	0.000686	CcSEcCtD
Pentazocine—Dyspnoea—Capecitabine—prostate cancer	0.000105	0.000686	CcSEcCtD
Pentazocine—Anaphylactic shock—Prednisone—prostate cancer	0.000105	0.000686	CcSEcCtD
Pentazocine—Nausea—Mitoxantrone—prostate cancer	0.000105	0.000683	CcSEcCtD
Pentazocine—Constipation—Docetaxel—prostate cancer	0.000104	0.00068	CcSEcCtD
Pentazocine—Chills—Epirubicin—prostate cancer	0.000104	0.000677	CcSEcCtD
Pentazocine—Pruritus—Etoposide—prostate cancer	0.000104	0.000677	CcSEcCtD
Pentazocine—Shock—Prednisone—prostate cancer	0.000103	0.000675	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—prostate cancer	0.000103	0.000673	CcSEcCtD
Pentazocine—Tachycardia—Prednisone—prostate cancer	0.000103	0.000669	CcSEcCtD
Pentazocine—Decreased appetite—Capecitabine—prostate cancer	0.000103	0.000669	CcSEcCtD
Pentazocine—Hyperhidrosis—Prednisone—prostate cancer	0.000102	0.000663	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—prostate cancer	0.000101	0.00066	CcSEcCtD
Pentazocine—Constipation—Capecitabine—prostate cancer	0.000101	0.000658	CcSEcCtD
Pentazocine—Feeling abnormal—Docetaxel—prostate cancer	0.0001	0.000655	CcSEcCtD
Pentazocine—Diarrhoea—Etoposide—prostate cancer	0.0001	0.000655	CcSEcCtD
Pentazocine—Anorexia—Prednisone—prostate cancer	0.0001	0.000654	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—prostate cancer	9.98e-05	0.000651	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—prostate cancer	9.94e-05	0.000648	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—prostate cancer	9.87e-05	0.000643	CcSEcCtD
Pentazocine—Feeling abnormal—Capecitabine—prostate cancer	9.73e-05	0.000634	CcSEcCtD
Pentazocine—Dizziness—Etoposide—prostate cancer	9.7e-05	0.000633	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—prostate cancer	9.69e-05	0.000632	CcSEcCtD
Pentazocine—Chills—Doxorubicin—prostate cancer	9.61e-05	0.000627	CcSEcCtD
Pentazocine—Insomnia—Prednisone—prostate cancer	9.51e-05	0.00062	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—prostate cancer	9.5e-05	0.000619	CcSEcCtD
Pentazocine—Paraesthesia—Prednisone—prostate cancer	9.44e-05	0.000616	CcSEcCtD
Pentazocine—Vomiting—Etoposide—prostate cancer	9.33e-05	0.000608	CcSEcCtD
Pentazocine—Agitation—Epirubicin—prostate cancer	9.26e-05	0.000604	CcSEcCtD
Pentazocine—Dermatitis—Etoposide—prostate cancer	9.24e-05	0.000603	CcSEcCtD
Pentazocine—Headache—Etoposide—prostate cancer	9.19e-05	0.000599	CcSEcCtD
Pentazocine—Decreased appetite—Prednisone—prostate cancer	9.14e-05	0.000596	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—prostate cancer	9.13e-05	0.000595	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—prostate cancer	9.05e-05	0.00059	CcSEcCtD
Pentazocine—Syncope—Epirubicin—prostate cancer	9.04e-05	0.000589	CcSEcCtD
Pentazocine—Constipation—Prednisone—prostate cancer	8.99e-05	0.000586	CcSEcCtD
Pentazocine—Hypersensitivity—Docetaxel—prostate cancer	8.98e-05	0.000586	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—prostate cancer	8.96e-05	0.000584	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—prostate cancer	8.86e-05	0.000577	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—prostate cancer	8.79e-05	0.000573	CcSEcCtD
Pentazocine—Asthenia—Docetaxel—prostate cancer	8.75e-05	0.00057	CcSEcCtD
Pentazocine—Nausea—Etoposide—prostate cancer	8.71e-05	0.000568	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—prostate cancer	8.7e-05	0.000567	CcSEcCtD
Pentazocine—Hypersensitivity—Capecitabine—prostate cancer	8.7e-05	0.000567	CcSEcCtD
Pentazocine—Feeling abnormal—Prednisone—prostate cancer	8.66e-05	0.000565	CcSEcCtD
Pentazocine—Pruritus—Docetaxel—prostate cancer	8.63e-05	0.000562	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—prostate cancer	8.57e-05	0.000559	CcSEcCtD
Pentazocine—Asthenia—Capecitabine—prostate cancer	8.47e-05	0.000552	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—prostate cancer	8.39e-05	0.000547	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—prostate cancer	8.38e-05	0.000546	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—prostate cancer	8.36e-05	0.000545	CcSEcCtD
Pentazocine—Pruritus—Capecitabine—prostate cancer	8.35e-05	0.000545	CcSEcCtD
Pentazocine—Diarrhoea—Docetaxel—prostate cancer	8.34e-05	0.000544	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—prostate cancer	8.29e-05	0.000541	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—prostate cancer	8.22e-05	0.000536	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—prostate cancer	8.19e-05	0.000534	CcSEcCtD
Pentazocine—Shock—Epirubicin—prostate cancer	8.09e-05	0.000528	CcSEcCtD
Pentazocine—Diarrhoea—Capecitabine—prostate cancer	8.08e-05	0.000527	CcSEcCtD
Pentazocine—Dizziness—Docetaxel—prostate cancer	8.06e-05	0.000526	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—prostate cancer	8.05e-05	0.000525	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—prostate cancer	8.03e-05	0.000523	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—prostate cancer	7.95e-05	0.000518	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—prostate cancer	7.84e-05	0.000511	CcSEcCtD
Pentazocine—Dizziness—Capecitabine—prostate cancer	7.81e-05	0.000509	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—prostate cancer	7.76e-05	0.000506	CcSEcCtD
Pentazocine—Vomiting—Docetaxel—prostate cancer	7.75e-05	0.000505	CcSEcCtD
Pentazocine—Hypersensitivity—Prednisone—prostate cancer	7.75e-05	0.000505	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—prostate cancer	7.68e-05	0.000501	CcSEcCtD
Pentazocine—Dermatitis—Docetaxel—prostate cancer	7.68e-05	0.000501	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—prostate cancer	7.67e-05	0.0005	CcSEcCtD
Pentazocine—Headache—Docetaxel—prostate cancer	7.64e-05	0.000498	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—prostate cancer	7.61e-05	0.000496	CcSEcCtD
Pentazocine—Asthenia—Prednisone—prostate cancer	7.54e-05	0.000492	CcSEcCtD
Pentazocine—Vomiting—Capecitabine—prostate cancer	7.5e-05	0.000489	CcSEcCtD
Pentazocine—Shock—Doxorubicin—prostate cancer	7.49e-05	0.000488	CcSEcCtD
Pentazocine—Pruritus—Prednisone—prostate cancer	7.44e-05	0.000485	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—prostate cancer	7.44e-05	0.000485	CcSEcCtD
Pentazocine—Dermatitis—Capecitabine—prostate cancer	7.44e-05	0.000485	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—prostate cancer	7.43e-05	0.000484	CcSEcCtD
Pentazocine—Headache—Capecitabine—prostate cancer	7.39e-05	0.000482	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—prostate cancer	7.38e-05	0.000481	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—prostate cancer	7.36e-05	0.00048	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—prostate cancer	7.33e-05	0.000478	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—prostate cancer	7.31e-05	0.000477	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—prostate cancer	7.25e-05	0.000473	CcSEcCtD
Pentazocine—Nausea—Docetaxel—prostate cancer	7.24e-05	0.000472	CcSEcCtD
Pentazocine—Diarrhoea—Prednisone—prostate cancer	7.19e-05	0.000469	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—prostate cancer	7.15e-05	0.000466	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—prostate cancer	7.11e-05	0.000464	CcSEcCtD
Pentazocine—Constipation—Epirubicin—prostate cancer	7.03e-05	0.000459	CcSEcCtD
Pentazocine—Nausea—Capecitabine—prostate cancer	7.01e-05	0.000457	CcSEcCtD
Pentazocine—Dizziness—Prednisone—prostate cancer	6.95e-05	0.000453	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—prostate cancer	6.88e-05	0.000449	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—prostate cancer	6.83e-05	0.000446	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—prostate cancer	6.78e-05	0.000442	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—prostate cancer	6.78e-05	0.000442	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—prostate cancer	6.76e-05	0.000441	CcSEcCtD
Pentazocine—Vomiting—Prednisone—prostate cancer	6.68e-05	0.000436	CcSEcCtD
Pentazocine—Dermatitis—Prednisone—prostate cancer	6.62e-05	0.000432	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—prostate cancer	6.61e-05	0.000431	CcSEcCtD
Pentazocine—Headache—Prednisone—prostate cancer	6.59e-05	0.00043	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—prostate cancer	6.51e-05	0.000424	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—prostate cancer	6.27e-05	0.000409	CcSEcCtD
Pentazocine—Nausea—Prednisone—prostate cancer	6.25e-05	0.000407	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—prostate cancer	6.06e-05	0.000395	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—prostate cancer	5.9e-05	0.000385	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—prostate cancer	5.82e-05	0.000379	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—prostate cancer	5.63e-05	0.000367	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—prostate cancer	5.61e-05	0.000366	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—prostate cancer	5.46e-05	0.000356	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—prostate cancer	5.44e-05	0.000355	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—prostate cancer	5.38e-05	0.000351	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—prostate cancer	5.23e-05	0.000341	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—prostate cancer	5.21e-05	0.000339	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—prostate cancer	5.18e-05	0.000338	CcSEcCtD
Pentazocine—Headache—Epirubicin—prostate cancer	5.15e-05	0.000336	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—prostate cancer	5.03e-05	0.000328	CcSEcCtD
Pentazocine—Nausea—Epirubicin—prostate cancer	4.88e-05	0.000319	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—prostate cancer	4.84e-05	0.000315	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—prostate cancer	4.79e-05	0.000313	CcSEcCtD
Pentazocine—Headache—Doxorubicin—prostate cancer	4.77e-05	0.000311	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—prostate cancer	4.52e-05	0.000295	CcSEcCtD
Pentazocine—OPRK1—Signaling Pathways—PARP1—prostate cancer	1.44e-05	0.000299	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAP3K7—prostate cancer	1.43e-05	0.000296	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CALCA—prostate cancer	1.42e-05	0.000295	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL12—prostate cancer	1.39e-05	0.000288	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF10—prostate cancer	1.37e-05	0.000285	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTHLH—prostate cancer	1.37e-05	0.000283	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFBR1—prostate cancer	1.37e-05	0.000283	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB2—prostate cancer	1.36e-05	0.000282	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKR1C3—prostate cancer	1.34e-05	0.000279	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—JAK2—prostate cancer	1.34e-05	0.000278	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKACB—prostate cancer	1.34e-05	0.000277	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAP2K1—prostate cancer	1.34e-05	0.000277	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CD—prostate cancer	1.33e-05	0.000275	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VAV3—prostate cancer	1.33e-05	0.000275	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CG—prostate cancer	1.32e-05	0.000274	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP9—prostate cancer	1.31e-05	0.000271	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFBR2—prostate cancer	1.31e-05	0.000271	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPP3CA—prostate cancer	1.3e-05	0.00027	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—THBS1—prostate cancer	1.3e-05	0.00027	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ITPR1—prostate cancer	1.29e-05	0.000267	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ANXA1—prostate cancer	1.28e-05	0.000266	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CD—prostate cancer	1.28e-05	0.000266	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—prostate cancer	1.28e-05	0.000265	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CB—prostate cancer	1.27e-05	0.000264	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCQ—prostate cancer	1.27e-05	0.000263	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGFR—prostate cancer	1.27e-05	0.000263	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCZ—prostate cancer	1.26e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAP3K7—prostate cancer	1.25e-05	0.00026	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CG—prostate cancer	1.23e-05	0.000255	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1R—prostate cancer	1.23e-05	0.000255	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—prostate cancer	1.22e-05	0.000254	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—JAK2—prostate cancer	1.22e-05	0.000252	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PARP1—prostate cancer	1.22e-05	0.000252	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGFR4—prostate cancer	1.22e-05	0.000252	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF10—prostate cancer	1.21e-05	0.00025	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALCA—prostate cancer	1.2e-05	0.000249	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—prostate cancer	1.19e-05	0.000247	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LPL—prostate cancer	1.18e-05	0.000244	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—JAK2—prostate cancer	1.18e-05	0.000244	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL12—prostate cancer	1.17e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAP2K1—prostate cancer	1.17e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—prostate cancer	1.17e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFRB—prostate cancer	1.17e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CD—prostate cancer	1.16e-05	0.000241	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VAV3—prostate cancer	1.16e-05	0.000241	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CB—prostate cancer	1.16e-05	0.00024	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFBR2—prostate cancer	1.15e-05	0.000238	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ITGB3—prostate cancer	1.14e-05	0.000236	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITPR1—prostate cancer	1.13e-05	0.000234	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—prostate cancer	1.12e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CB—prostate cancer	1.12e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—prostate cancer	1.11e-05	0.00023	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP9—prostate cancer	1.11e-05	0.000229	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB3—prostate cancer	1.1e-05	0.000229	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGFR2—prostate cancer	1.1e-05	0.000229	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CD—prostate cancer	1.08e-05	0.000225	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1R—prostate cancer	1.08e-05	0.000224	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—prostate cancer	1.07e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGFR—prostate cancer	1.07e-05	0.000222	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCQ—prostate cancer	1.07e-05	0.000222	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—JAK2—prostate cancer	1.07e-05	0.000221	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—prostate cancer	1.06e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAP3K7—prostate cancer	1.06e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TERT—prostate cancer	1.06e-05	0.000219	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—prostate cancer	1.04e-05	0.000216	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LPL—prostate cancer	1.03e-05	0.000214	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—prostate cancer	1.03e-05	0.000213	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFRB—prostate cancer	1.02e-05	0.000212	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF10—prostate cancer	1.02e-05	0.000211	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CB—prostate cancer	1.01e-05	0.00021	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HIF1A—prostate cancer	1.01e-05	0.00021	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—prostate cancer	1.01e-05	0.000209	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITGB3—prostate cancer	9.99e-06	0.000207	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—JAK2—prostate cancer	9.94e-06	0.000206	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAP2K1—prostate cancer	9.9e-06	0.000205	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—prostate cancer	9.89e-06	0.000205	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CD—prostate cancer	9.84e-06	0.000204	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VAV3—prostate cancer	9.83e-06	0.000204	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CAV1—prostate cancer	9.79e-06	0.000203	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—prostate cancer	9.75e-06	0.000202	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFBR2—prostate cancer	9.69e-06	0.000201	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB3—prostate cancer	9.69e-06	0.000201	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—prostate cancer	9.68e-06	0.000201	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGFR2—prostate cancer	9.67e-06	0.0002	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITPR1—prostate cancer	9.53e-06	0.000198	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CB—prostate cancer	9.44e-06	0.000196	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—prostate cancer	9.44e-06	0.000196	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—prostate cancer	9.32e-06	0.000193	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TERT—prostate cancer	9.28e-06	0.000192	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BAD—prostate cancer	9.21e-06	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1R—prostate cancer	9.12e-06	0.000189	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—prostate cancer	9.08e-06	0.000188	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—JAK2—prostate cancer	9.03e-06	0.000187	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—prostate cancer	8.92e-06	0.000185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APC—prostate cancer	8.92e-06	0.000185	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HIF1A—prostate cancer	8.88e-06	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGF—prostate cancer	8.82e-06	0.000183	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IRS1—prostate cancer	8.82e-06	0.000183	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LPL—prostate cancer	8.74e-06	0.000181	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—prostate cancer	8.67e-06	0.00018	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—prostate cancer	8.67e-06	0.00018	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFRB—prostate cancer	8.66e-06	0.000179	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CAV1—prostate cancer	8.59e-06	0.000178	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CB—prostate cancer	8.58e-06	0.000178	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GSK3B—prostate cancer	8.56e-06	0.000177	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—prostate cancer	8.49e-06	0.000176	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—prostate cancer	8.44e-06	0.000175	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGB3—prostate cancer	8.44e-06	0.000175	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—prostate cancer	8.28e-06	0.000171	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CREBBP—prostate cancer	8.27e-06	0.000171	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—prostate cancer	8.24e-06	0.000171	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB3—prostate cancer	8.19e-06	0.00017	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGFR2—prostate cancer	8.17e-06	0.000169	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—prostate cancer	8.17e-06	0.000169	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—prostate cancer	8.13e-06	0.000168	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BAD—prostate cancer	8.08e-06	0.000167	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAP2K1—prostate cancer	7.89e-06	0.000164	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—prostate cancer	7.88e-06	0.000163	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TERT—prostate cancer	7.85e-06	0.000163	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CD—prostate cancer	7.84e-06	0.000163	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—prostate cancer	7.82e-06	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APC—prostate cancer	7.82e-06	0.000162	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—prostate cancer	7.77e-06	0.000161	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—prostate cancer	7.76e-06	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGF—prostate cancer	7.73e-06	0.00016	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IRS1—prostate cancer	7.73e-06	0.00016	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—KRAS—prostate cancer	7.68e-06	0.000159	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF2—prostate cancer	7.51e-06	0.000156	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GSK3B—prostate cancer	7.51e-06	0.000156	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HIF1A—prostate cancer	7.5e-06	0.000156	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—prostate cancer	7.41e-06	0.000153	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—prostate cancer	7.41e-06	0.000153	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—prostate cancer	7.33e-06	0.000152	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CAV1—prostate cancer	7.26e-06	0.00015	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CREBBP—prostate cancer	7.25e-06	0.00015	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAK2—prostate cancer	7.2e-06	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—prostate cancer	7.18e-06	0.000149	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—prostate cancer	7.16e-06	0.000148	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—prostate cancer	7.13e-06	0.000148	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—prostate cancer	7.05e-06	0.000146	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MDM2—prostate cancer	7.03e-06	0.000146	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—prostate cancer	6.99e-06	0.000145	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB2—prostate cancer	6.93e-06	0.000144	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAP2K1—prostate cancer	6.92e-06	0.000143	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CD—prostate cancer	6.88e-06	0.000143	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CB—prostate cancer	6.84e-06	0.000142	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BAD—prostate cancer	6.83e-06	0.000141	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—prostate cancer	6.81e-06	0.000141	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—prostate cancer	6.8e-06	0.000141	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KRAS—prostate cancer	6.73e-06	0.00014	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APC—prostate cancer	6.61e-06	0.000137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	6.61e-06	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF2—prostate cancer	6.58e-06	0.000136	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—prostate cancer	6.57e-06	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGF—prostate cancer	6.54e-06	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IRS1—prostate cancer	6.54e-06	0.000135	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—prostate cancer	6.49e-06	0.000135	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	6.42e-06	0.000133	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	6.35e-06	0.000132	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GSK3B—prostate cancer	6.34e-06	0.000131	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAK2—prostate cancer	6.31e-06	0.000131	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—prostate cancer	6.29e-06	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—prostate cancer	6.28e-06	0.00013	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—prostate cancer	6.26e-06	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—prostate cancer	6.25e-06	0.000129	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	6.19e-06	0.000128	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MDM2—prostate cancer	6.16e-06	0.000128	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CREBBP—prostate cancer	6.13e-06	0.000127	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—prostate cancer	6.12e-06	0.000127	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB2—prostate cancer	6.07e-06	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	6.06e-06	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—prostate cancer	6.05e-06	0.000125	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—prostate cancer	6.02e-06	0.000125	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	5.99e-06	0.000124	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—prostate cancer	5.94e-06	0.000123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	5.92e-06	0.000123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTEN—prostate cancer	5.91e-06	0.000122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	5.85e-06	0.000121	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	5.81e-06	0.00012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—prostate cancer	5.76e-06	0.000119	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—prostate cancer	5.76e-06	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	5.76e-06	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	5.75e-06	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KRAS—prostate cancer	5.69e-06	0.000118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EP300—prostate cancer	5.63e-06	0.000117	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	5.63e-06	0.000117	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF2—prostate cancer	5.57e-06	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	5.56e-06	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—prostate cancer	5.51e-06	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—prostate cancer	5.5e-06	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—prostate cancer	5.49e-06	0.000114	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SRC—prostate cancer	5.48e-06	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—prostate cancer	5.48e-06	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—prostate cancer	5.37e-06	0.000111	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—prostate cancer	5.34e-06	0.000111	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAK2—prostate cancer	5.33e-06	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	5.31e-06	0.00011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—prostate cancer	5.28e-06	0.000109	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	5.23e-06	0.000108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—prostate cancer	5.21e-06	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MDM2—prostate cancer	5.21e-06	0.000108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	5.19e-06	0.000108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTEN—prostate cancer	5.18e-06	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB2—prostate cancer	5.13e-06	0.000106	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	5.07e-06	0.000105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—prostate cancer	5.05e-06	0.000105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EP300—prostate cancer	4.94e-06	0.000102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—prostate cancer	4.91e-06	0.000102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—prostate cancer	4.9e-06	0.000101	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—prostate cancer	4.87e-06	0.000101	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SRC—prostate cancer	4.8e-06	9.95e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—prostate cancer	4.8e-06	9.95e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	4.75e-06	9.85e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	4.7e-06	9.75e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—prostate cancer	4.68e-06	9.69e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—prostate cancer	4.66e-06	9.66e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—prostate cancer	4.65e-06	9.64e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—prostate cancer	4.63e-06	9.6e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—prostate cancer	4.63e-06	9.59e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KRAS—prostate cancer	4.54e-06	9.4e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—prostate cancer	4.54e-06	9.4e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	4.49e-06	9.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—prostate cancer	4.4e-06	9.12e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	4.39e-06	9.09e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTEN—prostate cancer	4.38e-06	9.07e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—prostate cancer	4.3e-06	8.92e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—prostate cancer	4.29e-06	8.9e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—prostate cancer	4.27e-06	8.85e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—prostate cancer	4.21e-06	8.72e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EP300—prostate cancer	4.17e-06	8.65e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	4.17e-06	8.64e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SRC—prostate cancer	4.06e-06	8.41e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—prostate cancer	4.03e-06	8.35e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KRAS—prostate cancer	3.98e-06	8.24e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—prostate cancer	3.95e-06	8.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—prostate cancer	3.92e-06	8.11e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—prostate cancer	3.69e-06	7.65e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	3.65e-06	7.57e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—prostate cancer	3.64e-06	7.54e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—prostate cancer	3.63e-06	7.52e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—prostate cancer	3.56e-06	7.37e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—prostate cancer	3.54e-06	7.33e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—prostate cancer	3.4e-06	7.05e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KRAS—prostate cancer	3.36e-06	6.97e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—prostate cancer	3.24e-06	6.71e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	3.09e-06	6.4e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—prostate cancer	2.99e-06	6.19e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—prostate cancer	2.99e-06	6.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—prostate cancer	2.73e-06	5.67e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—prostate cancer	2.52e-06	5.23e-05	CbGpPWpGaD
